![F5A F5A](https://data.pdbj.org/pdbjplus/data/cc/svg/F5A.svg) | F5A | Name: | 2-[4-(4-chlorobenzene-1-carbonyl)phenoxy]-2-methylpropanoic acid | Formula: | C17 H15 Cl O4 | SMILES: | C(C(=O)O)(C)(C)Oc1ccc(cc1)C(c2ccc(cc2)Cl)=O | InChi: | InChI=1S/C17H15ClO4/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11/h3-10H,1-2H3,(H,20,21) | Definition date: | 2019-01-23 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 2-[4-(4-chlorobenzene-1-carbonyl)phenoxy]-2-methylpropanoic acid |
|
![V4A V4A](https://data.pdbj.org/pdbjplus/data/cc/svg/V4A.svg) | V4A | Name: | Platinum(II) bis[3-(pyridin-2-yl)-[1,2,4]triazolo[4,3-a]pyridine] | Formula: | C22 H16 N8 Pt | SMILES: | c3cccc4c2n1c(cccc1)nn2[Pt+2]6(n34)n8c(c5ccccn56)n7c(cccc7)n8 | InChi: | InChI=1S/2C11H8N4.Pt/c2*1-3-7-12-9(5-1)11-14-13-10-6-2-4-8-15(10)11 | Definition date: | 2020-06-24 | Last modified: | 2020-10-30 | Release date: | 2020-11-04 | Identifier: | bis[3-(pyridin-2-yl-kappaN)[1,2,4]triazolo[4,3-a]pyridine-kappaN~2~]platinum(2+) |
|
![TJG TJG](https://data.pdbj.org/pdbjplus/data/cc/svg/TJG.svg) | TJG | Name: | 7-cyclopropyl-N-[trans-4-(2-hydroxypropan-2-yl)cyclohexyl]-1,8-naphthyridine-3-carboxamide | Formula: | C21 H27 N3 O2 | SMILES: | c4c(C(NC1CCC(C(C)(O)C)CC1)=O)cc3ccc(C2CC2)nc3n4 | InChi: | InChI=1S/C21H27N3O2/c1-21(2,26)16-6-8-17(9-7-16)23-20(25)15-11-14-5-10-18(13-3-4-13)24-19(14)22-12-15/h5,10-13,16-17,26H,3-4,6-9H2,1-2H3,(H,23,25)/t16-,17- | Definition date: | 2020-03-23 | Last modified: | 2020-10-30 | Release date: | 2020-11-04 | Identifier: | 7-cyclopropyl-N-[trans-4-(2-hydroxypropan-2-yl)cyclohexyl]-1,8-naphthyridine-3-carboxamide |
|
![SWS SWS](https://data.pdbj.org/pdbjplus/data/cc/svg/SWS.svg) | SWS | Name: | 7-(azetidin-1-yl)-~{N}-[4-(2-oxidanylpropan-2-yl)cyclohexyl]-1,6-naphthyridine-3-carboxamide | Formula: | C21 H28 N4 O2 | SMILES: | CC(C)(O)[CH]1CC[CH](CC1)NC(=O)c2cnc3cc(ncc3c2)N4CCC4 | InChi: | InChI=1S/C21H28N4O2/c1-21(2,27)16-4-6-17(7-5-16)24-20(26)15-10-14-12-23-19(25-8-3-9-25)11-18(14)22-13-15/h10-13,16-17,27H,3-9H2,1-2H3,(H,24,26)/t16-,17- | Definition date: | 2020-03-13 | Last modified: | 2020-10-30 | Release date: | 2020-11-04 | Identifier: | 7-(azetidin-1-yl)-~{N}-[4-(2-oxidanylpropan-2-yl)cyclohexyl]-1,6-naphthyridine-3-carboxamide |
|
![VFG VFG](https://data.pdbj.org/pdbjplus/data/cc/svg/VFG.svg) | VFG | Name: | N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide | Formula: | C5 H8 N4 O3 S2 | SMILES: | CCC(=O)Nc1nnc(S(N)(=O)=O)s1 | InChi: | InChI=1S/C5H8N4O3S2/c1-2-3(10)7-4-8-9-5(13-4)14(6,11)12/h2H2,1H3,(H2,6,11,12)(H,7,8,10) | Definition date: | 2020-08-07 | Last modified: | 2020-10-30 | Release date: | 2020-11-04 | Identifier: | N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide |
|
![VFM VFM](https://data.pdbj.org/pdbjplus/data/cc/svg/VFM.svg) | VFM | Name: | 2-methyl-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide | Formula: | C6 H10 N4 O3 S2 | SMILES: | CC(C)C(=O)Nc1nnc(S(N)(=O)=O)s1 | InChi: | InChI=1S/C6H10N4O3S2/c1-3(2)4(11)8-5-9-10-6(14-5)15(7,12)13/h3H,1-2H3,(H2,7,12,13)(H,8,9,11) | Definition date: | 2020-08-10 | Last modified: | 2020-10-30 | Release date: | 2020-11-04 | Identifier: | 2-methyl-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide |
|
![VGS VGS](https://data.pdbj.org/pdbjplus/data/cc/svg/VGS.svg) | VGS | Name: | 2,2-dimethyl-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide | Formula: | C7 H12 N4 O3 S2 | SMILES: | CC(C)(C(Nc1nnc(S(N)(=O)=O)s1)=O)C | InChi: | InChI=1S/C7H12N4O3S2/c1-7(2,3)4(12)9-5-10-11-6(15-5)16(8,13)14/h1-3H3,(H2,8,13,14)(H,9,10,12) | Definition date: | 2020-08-10 | Last modified: | 2020-10-30 | Release date: | 2020-11-04 | Identifier: | 2,2-dimethyl-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide |
|
![RX7 RX7](https://data.pdbj.org/pdbjplus/data/cc/svg/RX7.svg) | RX7 | Name: | 2-methyl-2-{[(3-methylthiophen-2-yl)methyl]amino}propan-1-ol | Formula: | C10 H17 N O S | SMILES: | c1(c(C)ccs1)CNC(C)(C)CO | InChi: | InChI=1S/C10H17NOS/c1-8-4-5-13-9(8)6-11-10(2,3)7-12/h4-5,11-12H,6-7H2,1-3H3 | Definition date: | 2020-02-28 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | 2-methyl-2-{[(3-methylthiophen-2-yl)methyl]amino}propan-1-ol |
|
![O0Z O0Z](https://data.pdbj.org/pdbjplus/data/cc/svg/O0Z.svg) | O0Z | Name: | (2~{S})-2-(butylamino)-3-(1~{H}-indol-3-yl)-~{N}-[2-[(4~{R})-1-(phenylmethyl)azepan-4-yl]ethyl]propanamide | Formula: | C30 H42 N4 O | SMILES: | CCCCN[CH](Cc1c[nH]c2ccccc12)C(=O)NCC[CH]3CCCN(CC3)Cc4ccccc4 | InChi: | InChI=1S/C30H42N4O/c1-2-3-17-31-29(21-26-22-33-28-14-8-7-13-27(26)28)30(35)32-18-15-24-12-9-19-34(20-16-24)23-25-10-5-4-6-11-25/h4-8,10-11,13-14,22,24,29,31,33H,2-3,9,12,15-21,23H2,1H3,(H,32,35)/t24-,29+/m1/s1 | Definition date: | 2020-01-16 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | (2~{S})-2-(butylamino)-3-(1~{H}-indol-3-yl)-~{N}-[2-[(4~{R})-1-(phenylmethyl)azepan-4-yl]ethyl]propanamide |
|
![QGD QGD](https://data.pdbj.org/pdbjplus/data/cc/svg/QGD.svg) | QGD | Name: | O-{(R)-hydroxy[(2R)-3-(icosyloxy)-2-(tetradecanoyloxy)propoxy]phosphoryl}-L-serine | Formula: | C40 H80 N O9 P | SMILES: | C(O)(C(COP(OCC(COCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)(=O)O)N)=O | InChi: | InChI=1S/C40H80NO9P/c1-3-5-7-9-11-13-15-16-17-18-19-20-21-23-25-27-29-31-33-47-34-37(35-48-51(45,46)49-36-38(41)40(43)44)50-39(42)32-30-28-26-24-22-14-12-10-8-6-4-2/h37-38H,3-36,41H2,1-2H3,(H,43,44)(H,45,46)/t37-,38+/m1/s1 | Definition date: | 2019-10-28 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | O-{(R)-hydroxy[(2R)-3-(icosyloxy)-2-(tetradecanoyloxy)propoxy]phosphoryl}-L-serine |
|
![RRB RRB](https://data.pdbj.org/pdbjplus/data/cc/svg/RRB.svg) | RRB | Name: | [(2~{R},3~{S},4~{R},5~{R})-5-[7-azanyl-5-(hydroxymethyl)benzimidazol-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl ~{N}-[(2~{S})-2-azanyl-3-(4-hydroxyphenyl)propanoyl]sulfamate | Formula: | C22 H27 N5 O9 S | SMILES: | N[CH](Cc1ccc(O)cc1)C(=O)N[S](=O)(=O)OC[CH]2O[CH]([CH](O)[CH]2O)n3cnc4cc(CO)cc(N)c34 | InChi: | InChI=1S/C22H27N5O9S/c23-14-6-12(8-28)7-16-18(14)27(10-25-16)22-20(31)19(30)17(36-22)9-35-37(33,34)26-21(32)15(24)5-11-1-3-13(29)4-2-11/h1-4,6-7,10,15,17,19-20,22,28-31H,5,8-9,23-24H2,(H,26,32)/t15-,17+,19+,20+,22+/m0/s1 | Definition date: | 2020-10-20 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | [(2~{R},3~{S},4~{R},5~{R})-5-[7-azanyl-5-(hydroxymethyl)benzimidazol-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl ~{N}-[(2~{S})-2-azanyl-3-(4-hydroxyphenyl)propanoyl]sulfamate |
|
![ND5 ND5](https://data.pdbj.org/pdbjplus/data/cc/svg/ND5.svg) | ND5 | Name: | 3-[(~{E})-[3,5-bis(bromanyl)-2-oxidanyl-phenyl]methylideneamino]oxypropanoic acid | Formula: | C10 H9 Br2 N O4 | SMILES: | OC(=O)CCON=Cc1cc(Br)cc(Br)c1O | InChi: | InChI=1S/C10H9Br2NO4/c11-7-3-6(10(16)8(12)4-7)5-13-17-2-1-9(14)15/h3-5,16H,1-2H2,(H,14,15)/b13-5+ | Definition date: | 2019-11-22 | Last modified: | 2020-10-16 | Release date: | 2020-10-21 | Identifier: | 3-[(~{E})-[3,5-bis(bromanyl)-2-oxidanyl-phenyl]methylideneamino]oxypropanoic acid |
|
![LP0 LP0](https://data.pdbj.org/pdbjplus/data/cc/svg/LP0.svg) | LP0 | Name: | (7Z)-7-(2-amino-1,3-thiazol-4-yl)-1,1,3-trihydroxy-10,10-dimethyl-1,6-dioxo-2,9-dioxa-5,8-diaza-1lambda~5~-phospha-3-boraundec-7-en-11-oic acid | Formula: | C10 H16 B N4 O9 P S | SMILES: | OP(O)(=O)OB(O)CNC(C(=N/OC(C)(C(O)=O)C)c1csc(n1)N)=O | InChi: | InChI=1S/C10H16BN4O9PS/c1-10(2,8(17)18)23-15-6(5-3-26-9(12)14-5)7(16)13-4-11(19)24-25(20,21)22/h3,19H,4H2,1-2H3,(H2,12,14)(H,13,16)(H,17,18)(H2,20,21,22)/b15-6- | Definition date: | 2019-07-25 | Last modified: | 2020-10-16 | Release date: | 2020-10-21 | Identifier: | (7Z)-7-(2-amino-1,3-thiazol-4-yl)-1,1,3-trihydroxy-10,10-dimethyl-1,6-dioxo-2,9-dioxa-5,8-diaza-1lambda~5~-phospha-3-boraundec-7-en-11-oic acid |
|
![PJ1 PJ1](https://data.pdbj.org/pdbjplus/data/cc/svg/PJ1.svg) | PJ1 | Name: | (2R)-1-[(4-chlorophenyl)(methyl)amino]-3-(1H-imidazol-1-yl)propan-2-ol | Formula: | C13 H16 Cl N3 O | SMILES: | c1(ccc(cc1)Cl)N(CC(Cn2ccnc2)O)C | InChi: | InChI=1S/C13H16ClN3O/c1-16(12-4-2-11(14)3-5-12)8-13(18)9-17-7-6-15-10-17/h2-7,10,13,18H,8-9H2,1H3/t13-/m1/s1 | Definition date: | 2019-08-07 | Last modified: | 2020-10-02 | Release date: | 2020-10-07 | Identifier: | (2R)-1-[(4-chlorophenyl)(methyl)amino]-3-(1H-imidazol-1-yl)propan-2-ol |
|
![LVW LVW](https://data.pdbj.org/pdbjplus/data/cc/svg/LVW.svg) | LVW | Name: | (2~{R})-1-prop-2-enoxy-3-selanyl-propan-2-ol | Formula: | C6 H12 O2 Se | SMILES: | O[CH](C[SeH])COCC=C | InChi: | InChI=1S/C6H12O2Se/c1-2-3-8-4-6(7)5-9/h2,6-7,9H,1,3-5H2/t6-/m1/s1 | Definition date: | 2019-09-23 | Last modified: | 2020-10-02 | Release date: | 2020-10-07 | Identifier: | (2~{R})-1-prop-2-enoxy-3-selanyl-propan-2-ol |
|
![GQU GQU](https://data.pdbj.org/pdbjplus/data/cc/svg/GQU.svg) | GQU | Name: | (3~{S},3~{a}~{S},6~{a}~{R})-2-[3-[3,5-bis(fluoranyl)phenyl]propanoyl]-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-3,3~{a},4,5,6,6~{a}-hexahydro-1~{H}-cyclopenta[c]pyrrole-3-carboxamide | Formula: | C24 H29 F2 N3 O4 | SMILES: | Fc1cc(F)cc(CCC(=O)N2C[CH]3CCC[CH]3[CH]2C(=O)N[CH](C[CH]4CCNC4=O)C=O)c1 | InChi: | InChI=1S/C24H29F2N3O4/c25-17-8-14(9-18(26)11-17)4-5-21(31)29-12-16-2-1-3-20(16)22(29)24(33)28-19(13-30)10-15-6-7-27-23(15)32/h8-9,11,13,15-16,19-20,22H,1-7,10,12H2,(H,27,32)(H,28,33)/t15-,16-,19-,20-,22-/m0/s1 | Definition date: | 2020-09-23 | Last modified: | 2020-10-02 | Release date: | 2020-10-07 | Identifier: | (3~{S},3~{a}~{S},6~{a}~{R})-2-[3-[3,5-bis(fluoranyl)phenyl]propanoyl]-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-3,3~{a},4,5,6,6~{a}-hexahydro-1~{H}-cyclopenta[c]pyrrole-3-carboxamide |
|
![EUX EUX](https://data.pdbj.org/pdbjplus/data/cc/svg/EUX.svg) | EUX | Name: | N-[2-(1-cyclopropylsulfonylpyrazol-4-yl)pyrimidin-4-yl]-7-(4-methylpiperazin-1-yl)-5-propan-2-yl-9-[2,2,2-tris(fluoranyl)ethoxy]pyrido[4,3-b]indol-3-amine | Formula: | C31 H34 F3 N9 O3 S | SMILES: | CC(C)n1c2cc(Nc3ccnc(n3)c4cnn(c4)[S](=O)(=O)C5CC5)ncc2c6c(OCC(F)(F)F)cc(cc16)N7CCN(C)CC7 | InChi: | InChI=1S/C31H34F3N9O3S/c1-19(2)43-24-14-28(38-27-6-7-35-30(39-27)20-15-37-42(17-20)47(44,45)22-4-5-22)36-16-23(24)29-25(43)12-21(41-10-8-40(3)9-11-41)13-26(29)46-18-31(32,33)34/h6-7,12-17,19,22H,4-5,8-11,18H2,1-3H3,(H,35,36,38,39) | Definition date: | 2020-01-29 | Last modified: | 2020-10-02 | Release date: | 2020-10-07 | Identifier: | ~{N}-[2-(1-cyclopropylsulfonylpyrazol-4-yl)pyrimidin-4-yl]-7-(4-methylpiperazin-1-yl)-5-propan-2-yl-9-[2,2,2-tris(fluoranyl)ethoxy]pyrido[4,3-b]indol-3-amine |
|
![DSM DSM](https://data.pdbj.org/pdbjplus/data/cc/svg/DSM.svg) | DSM | Name: | 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE | Formula: | C18 H22 N2 | SMILES: | c1cc3c(cc1)CCc2c(cccc2)N3CCCNC | InChi: | InChI=1S/C18H22N2/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20/h2-5,7-10,19H,6,11-14H2,1H3 | Synonyms: | Desipramine | Definition date: | 2007-07-17 | Last modified: | 2020-09-29 | Identifier: | 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N-methylpropan-1-amine |
|
![IXX IXX](https://data.pdbj.org/pdbjplus/data/cc/svg/IXX.svg) | IXX | Name: | 3-(5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE | Formula: | C19 H24 N2 | SMILES: | c1cc3c(cc1)CCc2c(cccc2)N3CCCN(C)C | InChi: | InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3 | Synonyms: | 5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dibenz[b,f]azepine | Definition date: | 2007-06-07 | Last modified: | 2020-09-28 | Identifier: | 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine |
|
![TKP TKP](https://data.pdbj.org/pdbjplus/data/cc/svg/TKP.svg) | TKP | Name: | 2-(3-chlorophenyl)-2-methylpropyl [(2S)-3-cyclohexyl-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-1-oxopropan-2-yl]carbamate | Formula: | C27 H40 Cl N3 O5 | SMILES: | CC(C)(COC(=O)NC(CC1CCCCC1)C(NC(CC2C(=O)NCC2)CO)=O)c3cc(ccc3)Cl | InChi: | InChI=1S/C27H40ClN3O5/c1-27(2,20-9-6-10-21(28)15-20)17-36-26(35)31-23(13-18-7-4-3-5-8-18)25(34)30-22(16-32)14-19-11-12-29-24(19)33/h6,9-10,15,18-19,22-23,32H,3-5,7-8,11-14,16-17H2,1-2H3,(H,29,33)(H,30,34)(H,31,35)/t19-,22-,23-/m0/s1 | Definition date: | 2020-03-24 | Last modified: | 2020-09-25 | Release date: | 2020-09-30 | Identifier: | 2-(3-chlorophenyl)-2-methylpropyl [(2S)-3-cyclohexyl-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-1-oxopropan-2-yl]carbamate |
|
![TKS TKS](https://data.pdbj.org/pdbjplus/data/cc/svg/TKS.svg) | TKS | Name: | 2-(3-chlorophenyl)-2-methylpropyl [(2S)-3-cyclohexyl-1-({(1R,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-1-sulfanylpropan-2-yl}amino)-1-oxopropan-2-yl]carbamate | Formula: | C27 H40 Cl N3 O5 S | SMILES: | C1C(CCCC1)CC(C(NC(C(S)O)CC2C(=O)NCC2)=O)NC(=O)OCC(C)(C)c3cc(Cl)ccc3 | InChi: | InChI=1S/C27H40ClN3O5S/c1-27(2,19-9-6-10-20(28)15-19)16-36-26(35)31-21(13-17-7-4-3-5-8-17)24(33)30-22(25(34)37)14-18-11-12-29-23(18)32/h6,9-10,15,17-18,21-22,25,34,37H,3-5,7-8,11-14,16H2,1-2H3,(H,29,32)(H,30,33)(H,31,35)/t18-,21-,22-,25+/m0/s1 | Definition date: | 2020-03-24 | Last modified: | 2020-09-25 | Release date: | 2020-09-30 | Identifier: | 2-(3-chlorophenyl)-2-methylpropyl [(2S)-3-cyclohexyl-1-({(1R,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-1-sulfanylpropan-2-yl}amino)-1-oxopropan-2-yl]carbamate |
|
![TKV TKV](https://data.pdbj.org/pdbjplus/data/cc/svg/TKV.svg) | TKV | Name: | N~2~-{[2-(3-chlorophenyl)-2-methylpropoxy]carbonyl}-N-{(1R,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-1-sulfanylpropan-2-yl}-L-leucinamide | Formula: | C24 H36 Cl N3 O5 S | SMILES: | CC(COC(=O)NC(C(NC(C(S)O)CC1C(=O)NCC1)=O)CC(C)C)(c2cc(Cl)ccc2)C | InChi: | InChI=1S/C24H36ClN3O5S/c1-14(2)10-18(21(30)27-19(22(31)34)11-15-8-9-26-20(15)29)28-23(32)33-13-24(3,4)16-6-5-7-17(25)12-16/h5-7,12,14-15,18-19,22,31,34H,8-11,13H2,1-4H3,(H,26,29)(H,27,30)(H,28,32)/t15-,18-,19-,22+/m0/s1 | Definition date: | 2020-03-24 | Last modified: | 2020-09-25 | Release date: | 2020-09-30 | Identifier: | N~2~-{[2-(3-chlorophenyl)-2-methylpropoxy]carbonyl}-N-{(1R,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-1-sulfanylpropan-2-yl}-L-leucinamide |
|
![YIC YIC](https://data.pdbj.org/pdbjplus/data/cc/svg/YIC.svg) | YIC | Name: | (2S)-2-[[(2S)-1-(3-cyclopentylpropanoyl)piperidin-2-yl]carbonylamino]-3-phenyl-propanoic acid | Formula: | C23 H32 N2 O4 | SMILES: | OC(=O)[CH](Cc1ccccc1)NC(=O)[CH]2CCCCN2C(=O)CCC3CCCC3 | InChi: | InChI=1S/C23H32N2O4/c26-21(14-13-17-8-4-5-9-17)25-15-7-6-12-20(25)22(27)24-19(23(28)29)16-18-10-2-1-3-11-18/h1-3,10-11,17,19-20H,4-9,12-16H2,(H,24,27)(H,28,29)/t19-,20-/m0/s1 | Definition date: | 2019-10-08 | Last modified: | 2020-09-25 | Release date: | 2020-09-30 | Identifier: | (2~{S})-2-[[(2~{S})-1-(3-cyclopentylpropanoyl)piperidin-2-yl]carbonylamino]-3-phenyl-propanoic acid |
|
![VW1 VW1](https://data.pdbj.org/pdbjplus/data/cc/svg/VW1.svg) | VW1 | Name: | (2S)-2-(4-cyanophenoxy)propanamide | Formula: | C10 H10 N2 O2 | SMILES: | N#Cc1ccc(OC(C(=O)N)C)cc1 | InChi: | InChI=1S/C10H10N2O2/c1-7(10(12)13)14-9-4-2-8(6-11)3-5-9/h2-5,7H,1H3,(H2,12,13) | Definition date: | 2020-09-17 | Last modified: | 2020-09-25 | Release date: | 2020-09-30 | Identifier: | (2S)-2-(4-cyanophenoxy)propanamide |
|
![VW4 VW4](https://data.pdbj.org/pdbjplus/data/cc/svg/VW4.svg) | VW4 | Name: | (2S)-2-phenylpropane-1-sulfonamide | Formula: | C9 H13 N O2 S | SMILES: | NS(CC(c1ccccc1)C)(=O)=O | InChi: | InChI=1S/C9H13NO2S/c1-8(7-13(10,11)12)9-5-3-2-4-6-9/h2-6,8H,7H2,1H3,(H2,10,11,12)/t8-/m1/s1 | Definition date: | 2020-09-17 | Last modified: | 2020-09-25 | Release date: | 2020-09-30 | Identifier: | (2S)-2-phenylpropane-1-sulfonamide |
|